Recent Events & Catalysts

Leerink Partners Maintains Outperform on Illumina, Raises Price Target to $210

Benzinga · today

Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate

Yahoo · today

Illumina (ILMN) Faces German Recall Order Over Element Sequencing Patent Ruling

Yahoo · 1d ago

Illumina expands Billion Cell Atlas program with new AI drug developers

Yahoo · 1d ago

Juno Bio Opens First CLIA-Certified Sequencing Lab Dedicated Entirely to Women's Health, Backed by Ada Ventures, Artesian, Illumina Accelerator, and Entrepreneur First

Yahoo · 1d ago

Element Biosciences Prevails in German Patent Case Against Illumina

Yahoo · 3d ago

Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $190

Benzinga · 3d ago

Alamar Hits A High Note On Alzheimer's Buzz

Yahoo · 4d ago

Departure/appointment of directors or officers

Filed 2026-06-23 · 25d ago

Submission of matters to a vote of security holders, Financial statements and exhibits

Filed 2026-05-26 · 53d ago

Results of operations (earnings release), Other events, Financial statements and exhibits

Filed 2026-04-30 · 79d ago · Material